{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:36:20Z","timestamp":1788298580573,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Gastrointestinal (GI) symptoms are common in Parkinson disease (PD), often preceding neurological manifestations; however, early diagnostic utility of GI biopsies remains controversial. Studies suggest aberrant deposition of alpha-synuclein (\u03b1-syn) follows step-wise progression in central nervous system though histologic interpretation of normal and aberrant staining patterns have shown variable results. This study examines whether GI \u03b1-syn mRNA expression combined with standard \u03b1-syn immunohistochemical staining enhance the role of GI biopsy in PD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>Four groups were examined, including pediatric (21) and adult control patients (18), PD clinic patients (17), and pathologically confirmed PD cases from hospital archives (16). Enteric nervous system \u03b1-syn staining was evaluated by immunohistochemistry in 33 PD and 39 controls. \u03b1-Syn mRNA levels were compared between patient groups using quantitative polymerase chain reaction and stomach and colon levels in PD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>PD patients had Lewy bodies (LB) and diffuse neuronal \u03b1-syn staining. GI tissues from elderly controls, children, and young adults exhibited diffuse positivity. LB were limited to PD. Myenteric plexus immunoreactivity varied in different regions. Widespread staining was noted within stomach and colon. Immunoreactivity was present within esophagus, appendix, and small bowel. \u03b1-Syn mRNA expression was highest in PD; however, levels varied between proximal and distal GI tract.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>\u03b1-Syn is normally present within young and elderly enteric nervous system; furthermore, while \u03b1-syn mRNA is always detectable, levels are highest and most variable in PD. This suggests that enteric \u03b1-syn may be altered in neurodegenerative disease. The presence of LB in the GI tract, not solely \u03b1-syn expression, may prove useful, distinguishing neurodegenerative disease patients from normal controls.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pai.0000000000000613","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T19:55:21Z","timestamp":1511294121000},"page":"543-548","source":"Crossref","is-referenced-by-count":12,"title":["Enteric Pathologic Manifestations of Alpha-Synucleinopathies"],"prefix":"10.1097","volume":"27","author":[{"given":"Michael","family":"Punsoni","sequence":"first","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Neurology, Rhode Island Hospital, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Resnick","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Donahue","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Fang","family":"Yang","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward G.","family":"Stopa","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-008-0409-8","article-title":"Evaluation of \u03b1-synuclein immunohistochemical methods used by invited experts","volume":"116","author":"Beach","year":"2008","journal-title":"Acta Neuropathologica"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Arizona Parkinson\u2019s Disease Consortium. Multi-organ distribution of phosphorylated alphasynuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/mds.23838","article-title":"Alpha-synuclein in colonic submucosa in early untreated Parkinson\u2019s disease","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov Disord"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1111\/j.1365-2982.2012.01887.x","article-title":"A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson\u2019s disease","volume":"24","author":"Pouclet","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci Lett"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"e12728","DOI":"10.1371\/journal.pone.0012728","article-title":"Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms","volume":"5","author":"Lebouvier","year":"2010","journal-title":"PloS One"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mds.25776","article-title":"Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders","volume":"29","author":"Gelpi","year":"2014","journal-title":"Mov Disord"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/mds.25966","article-title":"Peripheral alpha-synuclein and Parkinson\u2019s disease","volume":"29","author":"Olanow","year":"2014","journal-title":"Mov Disord"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.nbd.2011.08.014","article-title":"A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson\u2019s disease","volume":"45","author":"Pouclet","year":"2012","journal-title":"Neurobiol Dis"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/mds.25789","article-title":"Alimentary, my dear Watson? The challenges of enteric \u03b1-synuclein as a Parkinson\u2019s disease biomarker","volume":"29","author":"Visanji","year":"2014","journal-title":"Mov Disord"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1136\/gut.2008.162503","article-title":"Pathological lesions in colonic biopsies during Parkinson\u2019s disease","volume":"57","author":"Lebouvier","year":"2008","journal-title":"Gut"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","article-title":"Parkinson\u2019s disease: the presence of Lewy bodies in Auerbach\u2019s and Meissner\u2019s plexuses","volume":"76","author":"Wakabayashi","year":"1988","journal-title":"Acta Neuropathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/mds.21560","article-title":"Bowel movement frequency in late-life and incidental Lewy bodies","volume":"22","author":"Abbott","year":"2007","journal-title":"Mov Disord"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/mds.21076","article-title":"Association of olfactory dysfunction with incidental Lewy bodies","volume":"21","author":"Ross","year":"2006","journal-title":"Mov Disord"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","article-title":"Evidence that incidental Lewy body disease is pre-symptomatic Parkinson\u2019s disease","volume":"115","author":"Dickson","year":"2008","journal-title":"Acta Neuropathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.parkreldis.2014.08.006","article-title":"Olfactory dysfunction in incidental Lewy body disease and Parkinson's disease","volume":"20","author":"Driver-Dunckley","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neurobiolaging.2009.05.019","article-title":"Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?","volume":"32","author":"Frigerio","year":"2011","journal-title":"Neurobiol Aging"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-016-0072-9","article-title":"Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson\u2019s disease","volume":"11","author":"Majbour","year":"2016","journal-title":"Mol Neurodegener"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/scitranslmed.3002566","article-title":"Phosphorylated \u03b1-synuclein in Parkinson's disease","volume":"4","author":"Wang","year":"2012","journal-title":"Sci Transl Med"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1096\/fj.10-179192","article-title":"Phosphorylated \u03b1-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease","volume":"25","author":"Foulds","year":"2011","journal-title":"FASEB J"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.24648","article-title":"Pathological \u03b1-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients","volume":"79","author":"Stokholm","year":"2016","journal-title":"Ann Neurol"},{"key":"R24-20230922","first-page":"609","article-title":"Colonic mucosal \u03b1-synuclein lacks specificity as a biomarker for Parkinson disease","volume":"84","author":"Visanji","year":"2015","journal-title":"Am Acad Neurol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s00115-012-3575-9","article-title":"Gastrointestinal dysfunction in idiopathic Parkinson\u2019s disease","volume":"83","author":"Del Tredici","year":"2012","journal-title":"Der Nervenarzt"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/00365520310003200","article-title":"Constipation in idiopathic Parkinson\u2019s disease","volume":"38","author":"Jost","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1212\/WNL.57.3.456","article-title":"Frequency of bowel movements and the future risk of Parkinson\u2019s disease","volume":"57","author":"Abbott","year":"2001","journal-title":"Neurology"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J Neural Transm"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"issue":"suppl 1","key":"R30-20230922","first-page":"S78","article-title":"Evidence in favor of Braak staging of Parkinson\u2019s disease","volume":"25","author":"Dickson","year":"2010","journal-title":"Mov Disord"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/mds.25498","article-title":"Parkinson\u2019s disease: \u201cBraak\u201d to the future","volume":"28","author":"Blesa","year":"2013","journal-title":"Mov Disord"},{"issue":"suppl 1","key":"R32-20230922","first-page":"S83","article-title":"Examining Braak\u2019s hypothesis by imaging Parkinson\u2019s disease","volume":"25","author":"Brooks","year":"2010","journal-title":"Mov Disord"}],"container-title":["Applied Immunohistochemistry &amp; Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00129039-201908000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:11:33Z","timestamp":1695406293000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00129039-201908000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pai.0000000000000613","relation":{},"ISSN":["1541-2016"],"issn-type":[{"value":"1541-2016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}